The Princess Margaret Hospital Foundation
NEWSLETTER SIGN UP ABOUT UHN ABOUT THE PRINCESS MARGARET ABOUT CFI HOME
 
Featured Stories
Patient Stories
Donor Stories
Inside PMH Stories
Share Your Story
 
Donor Stories
Guided Therapeutics Combined with New Robotic Technology - Makes Powerful Medicine
 
 
A very generous gift from the Muzzo family has launched PMH into an exciting new era of surgical oncology.

In order to make surgery less invasive and allow patients to recover more quickly, PMH surgeons are now able to use robotics technology that allows them to perform surgery and remove tumours without ever touching a patient. Our expertise in guided therapeutics is being married with technology provided through the newly-acquired da Vinci Surgical System, enabling our surgeons to sit at a console and direct the robot’s actions using ‘joysticks’ or foot pedals.

Studies have shown that this type of minimally invasive surgery results in reduced toxicity, decreased treatment time, and overall better outcomes for the patient.

This important technology is also being used to train new surgeons and to develop and test new procedures. One of the most exciting applications of the new technology may be ‘telesurgery’ where a skilled surgeon could perform surgery on a patient thousands of kilometres away by operating the controls of a robot in that location.

“We are very proud to be affiliated with such a world-class facility and to be able to contribute to such leading edge technology with the potential to directly impact a patient’s recovery in a very difficult time,” says Marc Muzzo.


The Weekend to End Breast Cancer - Register for 2010
Welcome Home Sweepstakes
The Campbell Family Cancer Research Institute
Ride to Conquer Cancer
First research to determine that Hodgkin's disease can be cured by radiation therapy was at PMH, boosting the cure rate to 75% from 25%.
»More...

 Charitable Org. #: 88900 7597 RR0001
  Update Your Donor Info
»click here
  Send a Tribute Card to Someone Special
»click here
  Net Funds Raised in Fiscal 2012:
$84.2 million